Beuscart Jean-Baptiste, Pagniez Dominique, Boulanger Eric, Duhamel Alain
Department of Biostatistics, EA2694, Lille School of Medicine, Lille2 University.
J Epidemiol. 2015;25(2):133-41. doi: 10.2188/jea.JE20130193. Epub 2014 Dec 20.
Access to the renal transplantation (RT) waiting list depends on factors related to lower mortality rates and often occurs after dialysis initiation. The aim of the study was to use a flexible regression model to determine if registration on the RT waiting list is associated with mortality on dialysis, independent of the comorbidities associated with such registration.
Data from the French REIN registry on 7138 incident hemodialysis (HD) patients were analyzed. A multi-state model including four states ('HD, not wait-listed', 'HD, wait-listed', 'death', and 'RT') was used to estimate the effect of being wait-listed on the probability of death.
During the study, 1392 (19.5%) patients were wait-listed. Of the 2954 deaths observed in the entire cohort during follow-up, 2921 (98.9%) were observed in the not wait-listed group compared with only 33 (1.1%) in the wait-listed group. In the multivariable analysis, the adjusted hazard ratio for death associated with non-registration on the waiting list was 3.52 (95% CI, 1.70-7.30). The risk factors for death identified for not wait-listed patients were not found to be significant risk factors for wait-listed patients, with the exception of age.
The use of a multi-state model allowed a flexible analysis of mortality on dialysis. Patients who were not wait-listed had a much higher risk of death, regardless of co-morbidities associated with being wait-listed, and did not share the same risk factors of death as wait-listed patients. Registration on the waiting list should therefore be taken into account in survival analysis of patients on dialysis.
进入肾移植(RT)等待名单取决于与较低死亡率相关的因素,且通常在开始透析后发生。本研究的目的是使用灵活回归模型来确定在RT等待名单上登记是否与透析患者的死亡率相关,独立于与该登记相关的合并症。
分析了来自法国REIN登记处的7138例新发血液透析(HD)患者的数据。使用包括四个状态(“HD,未列入等待名单”、“HD,列入等待名单”、“死亡”和“RT”)的多状态模型来估计列入等待名单对死亡概率的影响。
在研究期间,1392例(19.5%)患者被列入等待名单。在随访期间整个队列中观察到的2954例死亡中,2921例(98.9%)在未列入等待名单的组中观察到,而在列入等待名单的组中仅观察到33例(1.1%)。在多变量分析中,与未在等待名单上登记相关的死亡调整风险比为3.52(95%CI,1.70 - 7.30)。未列入等待名单患者中确定的死亡风险因素,除年龄外,未被发现是列入等待名单患者的显著风险因素。
使用多状态模型允许对透析患者的死亡率进行灵活分析。未列入等待名单的患者死亡风险要高得多,无论与列入等待名单相关的合并症如何,并且与列入等待名单的患者没有相同的死亡风险因素。因此,在透析患者的生存分析中应考虑在等待名单上的登记情况。